Stage IIA Prostate Cancer Terminated Phase 2 Trials for Goserelin (DB00014)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00937768Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyTreatment